Transpact Medtech Private Limited
About Transpact Medtech Private Limited
Data last updated:
Transpact Medtech Private Limited is a private limited company based in Mumbai, Maharashtra, India. It was incorporated on 26 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U86904MH2023PTC403595.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammed Aslam Qudratullah Khan and Rehana Mohammed Aslam Khan.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.52 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2,976 (net margin 2%) and EBITDA of ₹5,369 (EBITDA margin 3.5%).
The company is associated with 1 brand: Transpact.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address204 Timmy Arcade Prem. Co – Op. Soc. Ltd, Makwana Road Andheri East, Mumbai, Maharashtra, India – 400059
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Transpact Medtech Private Limited
Transpact Medtech operates one associated brand: Transpact. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of a therapeutic device to stimulate the vestibular system | transpact.in |
Financials of Transpact Medtech Private Limited FY 2025 filings available
Transpact Medtech Private Limited reported revenue of ₹1.52 Lakh (up 160% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Transpact Medtech Private Limited
Revenue rose 160% in the latest year. EBITDA rose 43% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Transpact Medtech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹5,369 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹2,976 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Transpact Medtech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.5% | •••• |
| Net Profit Margin | 2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Transpact Medtech are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Transpact Medtech Private Limited
Transpact Medtech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Aslam Qudratullah Khan | Director | 26 May 2023 | 3 Years 4 Months | Current |
| Rehana Mohammed Aslam Khan Also directs: Centrium Healthcare Services Private Limited | Additional Director | 08 Aug 2024 | 2 Years 2 Months | Current |
Charges & Borrowings of Transpact Medtech Private Limited
Transpact Medtech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Transpact Medtech Private Limited
Employment history and EPFO contributions of people linked to Transpact Medtech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Transpact Medtech Private Limited
Transpact Medtech Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Rehana Mohammed Aslam Khan was appointed as Additional Director on 08 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Transpact Medtech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Transpact Medtech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Transpact Medtech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Transpact Medtech Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Transpact Medtech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transpact Medtech Private Limited
Transpact Medtech is an active private limited company based in Mumbai, Maharashtra, India. It was incorporated on 26 May 2023 (3+ years old) and is registered under CIN U86904MH2023PTC403595.
Transpact Medtech reported revenue of ₹1.52 Lakh for FY 2025 (up 160% YoY).
Transpact Medtech has 2 current directors:
- Mohammed Aslam Qudratullah Khan - Director
- Rehana Mohammed Aslam Khan - Additional Director
Transpact Medtech reported a net profit of ₹2,976 (net margin 2%) and EBITDA of ₹5,369 (EBITDA margin 3.5%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Transpact Medtech is U86904MH2023PTC403595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Transpact Medtech was incorporated on 26 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Rehana Mohammed Aslam Khan was appointed as Additional Director on 08 Aug 2024. Anis Ahmed Choudhery was appointed as Director on 26 May 2023. Mohammed Aslam Qudratullah Khan was appointed as Director on 26 May 2023.
The registered office of Transpact Medtech is at 204 Timmy Arcade Prem. Co – Op. Soc. Ltd, Makwana Road Andheri East, Mumbai, Maharashtra, India – 400059.
Transpact Medtech has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
No. Transpact Medtech is not listed on any stock exchange. It is an unlisted company.